EVP R&D, Chief Medical Officer
Wed, Oct 15, 2025
Oct 15
9,000 shares @ $31.53
Decreased holdings by -10.90%
31st largest trade (out of 157)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 7% above 200-day moving average